Molly Henderson

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

URGN

Current role

CFO

2020-10-01–present

6 calls Latest call 2022-03-21

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	UroGen Pharma Ltd. (URGN)	Former Chief Financial Officer	$434,113	—	$44,140	$267,023	$99,700	$59,782	$904,759
2020	UroGen Pharma Ltd. (URGN)	Former Chief Financial Officer	$94,269	$100,000	$294,900	$787,994	$69,875	$15,192	$1,362,230

Earnings-call appearances and filed executive appointments or departures, newest first.